Advances in the study of the anti-tumor activity of small molecule vascular disrupting agents / 药学学报
Acta Pharmaceutica Sinica
;
(12): 283-288, 2010.
Article
Dans Chinois
| WPRIM
| ID: wpr-250590
ABSTRACT
Vascular disrupting agents (VDAs) have presented a new kind of anti-cancer drug in recent years. VDAs take advantage of the weakness of established tumor endothelial cells and their supporting structures. In contrast to anti-angiogenic therapy, which inhibits the outgrowth of new blood vessels, vascular targeting treatments selectively attack the existing tumor vasculature. Here we summarized the anti-tumor activities, mechanisms and clinical applications of small molecule VDAs.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Oligopeptides
/
Composés organiques du phosphore
/
Anatomopathologie
/
Pharmacologie
/
Sérine
/
Stilbènes
/
Bibenzyles
/
Structure moléculaire
/
Chimie
/
Diphosphates
Limites du sujet:
Animaux
/
Humains
langue:
Chinois
Texte intégral:
Acta Pharmaceutica Sinica
Année:
2010
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS